$1.24 Billion is the total value of Opti Capital Management, LP's 42 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 63.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | WORKIVA INCnote 1.125% 8/1 | $58,863,000 | -14.9% | 36,338,000 | -6.9% | 4.74% | -9.7% | |
| Sell | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $38,559,000 | +0.5% | 42,382,000 | -0.1% | 3.10% | +6.6% | |
| Sell | AVAYA HLDGS CORPnote 2.250% 6/1 | $25,300,000 | -22.5% | 25,792,000 | -16.0% | 2.04% | -17.8% | |
| Sell | NUVASIVE INCnote 1.000% 6/0 | $17,937,000 | -10.9% | 17,910,000 | -10.0% | 1.44% | -5.4% | |
| Sell | NOVA LTDnote 10/1 | $15,514,000 | -67.8% | 10,000,000 | -58.8% | 1.25% | -65.9% | |
| Sell | KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $9,548,000 | -21.9% | 11,460,000 | -23.4% | 0.77% | -17.1% | |
| Sell | VIAVI SOLUTIONS INCnote 1.000% 3/0 | $4,040,000 | -38.0% | 3,096,000 | -32.6% | 0.32% | -34.2% | |
| Exit | BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $0 | – | -8,095,000 | -100.0% | -0.65% | – | |
| Exit | LENDINGTREE INCnote 0.500% 7/1 | $0 | – | -11,500,000 | -100.0% | -0.73% | – | |
| Exit | MANDIANT INCnote 0.875% 6/0 | $0 | – | -10,216,000 | -100.0% | -0.81% | – | |
| Exit | COHERUS BIOSCIENCES INCnote 1.500% 4/1 | $0 | – | -17,650,000 | -100.0% | -1.49% | – | |
| Exit | FORTIVE CORPnote 0.875% 2/1 | $0 | – | -21,927,000 | -100.0% | -1.66% | – | |
| Exit | REPLIGEN CORPnote 0.375% 7/1 | $0 | – | -10,534,000 | -100.0% | -1.88% | – | |
| Exit | NATIONAL VISION HLDGS INCnote 2.500% 5/1 | $0 | – | -16,591,000 | -100.0% | -2.12% | – | |
| Exit | RAMBUS INC DELnote 1.375% 2/0 | $0 | – | -18,000,000 | -100.0% | -2.15% | – | |
| Exit | VONAGE HLDGS CORPnote 1.750% 6/0 | $0 | – | -21,880,000 | -100.0% | -2.23% | – | |
| Exit | ETSY INCnote 0.125%10/0 | $0 | – | -27,500,000 | -100.0% | -5.33% | – | |
| Exit | ZSCALER INCnote 0.125% 7/0 | $0 | – | -41,140,000 | -100.0% | -6.84% | – | |
| Exit | NATERA INCnote 2.250% 5/0 | $0 | – | -37,362,000 | -100.0% | -7.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SUPERNUS PHARMACEUTICALS INC | 14 | Q1 2023 | 6.9% |
| NEW RELIC INC | 14 | Q1 2023 | 7.6% |
| 8X8 INC NEW | 13 | Q3 2023 | 7.4% |
| MANDIANT INC | 12 | Q1 2022 | 9.9% |
| NUTANIX INC | 12 | Q4 2022 | 7.3% |
| OPKO HEALTH INC | 12 | Q3 2023 | 2.1% |
| INSIGHT ENTERPRISES INC | 10 | Q3 2023 | 5.6% |
| ALTERYX INC | 10 | Q3 2023 | 4.6% |
| IONIS PHARMACEUTICALS INC | 10 | Q1 2023 | 3.6% |
| MODEL N INC | 10 | Q3 2023 | 1.7% |
View Opti Capital Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Opti Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.